FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32936811000001108: Tobramycin 170mg/1.7ml nebuliser liquid ampoules (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100372301000001110 Tobramycin 170mg/1.7ml nebuliser liquid ampoules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100372401000001119 Tobramycin 170mg/1.7ml nebuliser liquid ampoules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Inhalation true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutionnebuliser.inhalation ontology form and route true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Is a Tobramycin true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has dispensed dose form Nebuliser liquid false Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Is a Product containing tobramycin false Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has active ingredient Tobramycin false Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has specific active ingredient Tobramycin true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules Has manufactured dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Is a True Tobramycin 170mg/1.7ml nebuliser liquid ampoules Inferred relationship Existential restriction modifier
Tobramycin 170mg/1.7ml nebuliser liquid ampoules 56 ampoule Has VMP True Tobramycin 170mg/1.7ml nebuliser liquid ampoules Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start